Basics Biofrontera Inc. IPO Date: October 29, 2021 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $9.01M Activated in VL: True Average Daily Range Avg Daily Range: $0.13 | 5.04% Avg Daily Range (30 D): $0.03 | 3.08% Avg Daily Range (90 D): $0.03 | 3.74% Institutional Daily Volume Avg Daily Volume: 1.46M Avg Daily Volume (30 D): .17M Avg Daily Volume (90 D): .15M Trade Size Avg Trade Size (Sh.): 234 Avg Trade Size (Sh.) (30 D): 222 Avg Trade Size (Sh.) (90 D): 300 Institutional Trades Total Inst.Trades: 27 Avg Inst. Trade: $1.17M Avg Inst. Trade (30 D): $2.12M Avg Inst. Trade (90 D): $2.12M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 4.51K     News Aug 14, 2025 @ 7:01 PM Biofrontera Q2 Revenue Jumps 15% Source: Hermann Luebbert Aug 13, 2025 @ 9:20 PM Biofrontera Inc. Reports Second Quarter 2025 Finan... Source: Hermann Luebbert Aug 4, 2025 @ 6:00 PM Biofrontera Inc. to Report Second Quarter FY 2025 ... Source: Andrew Barwicki Jun 11, 2025 @ 7:00 PM BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGE... Source: N/A May 1, 2025 @ 6:38 PM Biofrontera and Almirall Launch the Hats On Challe... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.33 $-.47 $.17 Diluted EPS $-1.33 $-.47 $.17 Revenue $ 38M $ 8.59M $ 12.56M Gross Profit $ $ $ Net Income / Loss $ -11.53M $ -4.2M $ -1.4M Operating Income / Loss $ -16.29M $ -4.55M $ -1.71M Cost of Revenue $ $ $ Net Cash Flow $ 3.77M $ -4.12M $ 3.03M PE Ratio     Splits Jul 05, 2023:   1:20